Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_assertion type Assertion NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_head.
- NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_assertion description "[Intraplantar co-application of flagellin and QX-314 (flagellin/QX-314) dose-dependently suppresses mechanical allodynia after chemotherapy, nerve injury, and diabetic neuropathy, but this blockade is abrogated in Tlr5-deficient mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_provenance.
- NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_assertion evidence source_evidence_literature NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_provenance.
- NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_assertion SIO_000772 26479925 NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_provenance.
- NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_assertion wasDerivedFrom befree-2016 NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_provenance.
- NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_assertion wasGeneratedBy ECO_0000203 NP1295072.RA2TQqqow4VA6I7juN3dZ1O9pIuHX8C6i2VVSq-gJaYTE130_provenance.